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BACKGROUND: This study was carried out to investigate the association of Cross Linked C-Telopeptide Type I & II Collagen (CTX-I and 
II) and hyaluronic acid (HA) with knee osteoarthritis (OA) 
severity.
METHODS: Sixty menopause women with primary knee 
OA were enrolled in this study during their visits to the 
Outpatient Department. Patients with knee pain during 
weight bearing, active or passive range of motion, or 
tenderness with Kellgren-Lawrence (KL) grade of more 
than I were included. Patients with injury, inflammatory and 
metabolic diseases were excluded. Patients were put in a 10-
hour fasting prior to withdrawal of morning blood samples 
for examinations of HA, CTX-I, interleukin 1 beta (IL-
1b), and high sensitivity C reactive protein (hs-CRP) level. 
Second void morning urine specimens were taken for CTX-
II assessment. HA, CTX-I and II levels were measured by 
enzyme-linked immunosorbent assay.
RESULTS: Sixty menopausal female patients were included 
in this study, 35 with KL grade II, 17 grade III, and 8 grade 
IV. Means of CTX-II  were significantly different between 
subjects KL grade IV and  III (p=0.021). Correlation of KL 
grade was significant with CTX-II (p=0.001, r=0.412) and 
HA (p=0.0411, r=0.269). KL grades were not significantly 
associated with CTX-I (p=0.8364, r=-0.0272); IL-1β 
(p=0.5773, r=0.0853) and hs-CRP (p=0.2625, r=0.1470). 
CONCLUSION: CTX-II and HA were associated with 
severity of knee OA, suggesting that CTX-II and HA can be 
used as marker for knee OA severity.
LATAR BELAKANG: Untuk mengetahui hubungan antara Cross Linked C-Telopeptide Type I & II Collagen (CTX-I dan II), dan hyaluronic 
acid (HA) dengan keparahan osteoarthritis (OA) pada lutut.
METODE: Penelitian ini melibatkan 60 wanita menopause 
dengan OA lutut pada bagian rawat jalan, dengan keluhan 
nyeri lutut saat mengangkat beban, melakukan gerakan 
aktif dan pasif, atau tingkat kelembutan yang masuk dalam 
Kellgren-Lawrence (KL) grade lebih dari I. Pasien dengan 
luka, inflamasi dan penyakit metabolik dieksklusi. Pasien 
diminta untuk puasa selama 10 jam sebelum pengambilan 
darah di pagi hari untuk pemeriksaan kadar HA, CTX-I, 
interleukin 1 beta (IL-1b) dan high sensitivity C reactive 
protein (hs-CRP). Sampel urin kedua di pagi hari diambil 
untuk pemeriksaan CTX-II. HA, CTX-I dan II diperiksa 
dengan enzyme-linked immunosorbent assay.
HASIL: Enampuluh wanita menopause mengikuti 
penelitian ini, 35 dalam kelompok KL tingkat II, 17 tingkat 
III, dan 8 tingkat IV. Rerata CTX-II  berbeda bermakna 
antara subyek KL tingkat III dan IV (p=0,021). Ditemukan 
korelasi yang bermakna antara tingkatan KL dengan CTX-II 
(p=0,001, r=0,412), dan HA (p=0,0411, r=0,269). Tingkat 
KL tidak berkorelasi bermakna dengan CTX-I (p=0,8364, 
r=-0,0272), IL-1β (p=0,5773, r=0,0853) dan hs-CRP 
(p=0.2625, r=0.1470).
KESIMPULAN: CTX-II dan HA berhubungan dengan 
tingkat keparahan OA lutut, sehingga CTX-II dan HA dapat 
digunakan sebagai penanda untuk keparahan OA.
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As a chronic progressive disorder, knee osteoarthritis (OA) 
is marked by damage on cartilage and subchondral bone, 
and synovial thickening. The damage is a manifestation of 
imbalance between degradation and repair processes.(1) 
The extent of OA assessed by radiographic characteristics 
cannot be used in early diagnosis and prediction of 
progression due to low sensitivity. Therefore, developing 
a more sensitive indicator that can be used alongside with 
radiographic technique is important.(2)
 Many efforts have been done to identify specific 
indicators using imaging and biomarker parameters.(3) Type 
I collagen, composed of nearly 90% organic matrix of bone, 
consists of triple helix of the two chains, alpha 1 and alpha 2. 
Level of urinary cross linked C-telopeptide type I collagen 
(CTX-I) was found higher in patients with progressive 
OA compared to non-progressive one and control.(4) 
C-telopeptide type II collagen (CTX-II) is a constituent of 
the articular cartilage and hyaline cartilage. Urinary CTX-
II correlated with pain, malfunction, joint gap narrowing 
and subchondral sclerosis.(5) Hyaluronic acid (HA) is a 
precursor of synovium and cartilage. Increased levels of HA 
in the blood occurs in osteoarthritis.(6)  Several studies have 
shown that HA and CTX-II related to the severity of OA(7-
15), but one study reported no correlation was found(16). 
Most studies were done on Caucasian subjects.
KEYWORDS: CTX-II, hyaluronic acid, otestoarthritis, 
knee
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Subjects
Sixty menopause women with primary knee OA were 
enrolled  to this study. Patients with knee pain during weight 
bearing, active or passive range of motion, or tenderness 
with Kellgren-Lawrence (KL) grade of more than grade I 
were included. Subjects underwent weight-bearing postero-
anterior (PA) radiography and weight-bearing lateral 
radiography. Patients with inflammatory joint disease such 
as rheumatoid arthritis were excluded.
Blood Samples Collection and Assessment
Fasting morning blood samples were collected for HA, 
CTX-I and high sensitivity C-reactive protein (hs-CRP) 
Introduction
Methods
assessment. Serum HA was measured with enzyme-
linked immunosorbent assay (ELISA)  (Cat. No.: 029-
001, Corgenix, Broomfield, CO). CTX-I was measured 
by β-Crosslaps ELISA with sensitivity of 10 pg/ml (Cat. 
No.: 11972308, Roche, Indianapolis, IN). Meanwhile high 
sensitivity C reactive protein (hs-CRP) was measured using 
Cobas Integra, with standard range ≤ 10 mg/L.
Urine Samples Collection and Assessment
Morning second void urine specimens were taken for CTX-
II assessment as recommended in a previous study based on 
diurnal and activity related variation(17,18). Samples  were 
measured  using Urine CartiLaps EIA with sensitivity 0.20 
mg/ml (Immunodiagnostic Systems Ltd., Boldon, UK).
Articular fluid
Articular fluid of minimum 1 mL was taken for Interleukin 1 
beta (IL-1b) analysis. Samples were measured using ELISA 
with sensitivity 1 pg/ml (R&D System, Minneapolis, MN). 
Radiographs
Subjects underwent weight-bearing PA knee radiography 
in mild flexion.(19) KL grading system was used to 
assess severity of OA, which included the formation of 
osteophytes, joint space narrowing, subchondral sclerosis 
and joint deformity. OA was classified based on KL grading 
into 5 grades: grade 0 (normal), grade 1 (doubtful OA), 
grade 2 (minimal OA), grade 3 (moderate OA), and grade 
4 (severe OA). X-Ray was read by an orthopedic surgeon 
and a trained radiologist with inter-rater reliability kappa 
test 0.797.
Data Analysis
Data analysis was done by SPSS version 20.0 (IBM Corp., 
Armonk, NY). Analysis of mean differences of biomarkers 
among the KL groups was done using Mann-Whitney U 
Test, and p<0.05 was  defined  as significant. The association 
between biomarkers and KL grades was analyzed using 
spearman correlation test.
Results
Sixty menopausal female patients were included in this 
study. Thirty five subjects (58%) having KL grade II, 
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Mean ± SD Minimum Maximum
58.420 ± 9.803 42 83
27.000 ± 4.480 20 39.26
32.5%
17/28.3%
0.480 ± 0.230 0.12 1.18
719.630 ± 438.560 107 2213
213.580 ± 227.940 57 1489
2.110 ± 2.230 0 11.81
4.190 ± 4.730 0.20 26.20
     HA (ng/mL)
     IL-1β (pg/mL)
     hs-CRP (mg/L)
            Left (%)
            Right (%)
            Grade II (n/%)
            Grade III (n/%)
            Grade IV (n/%)
     KL Grade
35/ 58.3%
8/13.3%
     CTX -I (ng/mL)
     CTX-II (ng/mmol)
Variable
     Age (year)
     BMI (kg/m2)
     Affected Knee
67.5%
Table 1. Distribution of Demographic, Radiographic and Laboratory Results.
N Mean ± SD p
35 0.490 ±  0.250
17 0.438 ±  0.210 0.5070*
8 0.470 ±  0.180 0.4660**
34 506.940 ±  291.910
16 731.140 ±  428.460 0.0650*
8 1004.900 ±  265.060 0.0210**
34 158.800 ±  71.100
16 198.550 ±  103.590 0.2277*
8 209.850 ±  93.420 0.1510**
23 2.120 ±  2.170
14 1.350 ±  0.430 0.4701*
8 2.180 ±  1.500 0.0983**
35 1.900  ± 2.520
17 5.420 ±  5.440 0.4293*
8 4.270 ±  3.130 0.8714**
          KL 3
          KL 4
          KL 2
          KL 3
          KL 4
          KL 3
          KL 4
          KL 2
          KL 3
          KL 4
          KL 2
Variable
     CTX-I
     CTX-II
     HA
     IL-1β
     hs-CRP
          KL 2***
          KL 3
          KL 4
          KL 2
Table 2. Mean Difference Test for Biomarkers in KL Group.
*: Mann-Whitney U Test KL 3 vs. KL 2; **: Mann-Whitney U Test KL 4 vs KL 3
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      R      p  value
     CTX-I -0.0272 0.8364
     CTX-II 0.4120 0.0010
     HA 0.2690 0.0411
     IL-1 β 0.0853 0.5773
     hs-CRP 0.1470 0.2625
KL
Variable
Tabel 3. Correlation of Biomarker with Kellgreen.
17 subjects (28%)  having KL grade III, and 8 subjects 
(13%)  having KL grade IV. Two urine samples for CTX-
II examination and two blood samples for HA examination 
were spoiled hence not eligible for analysis. Fifteen samples 
of articular fluid for IL-1b examination were not adequately 
taken, thus not eligible for analysis. The average age of 
the participants was 58.42 years (42-83 years old) and the 
average body mass index was 27±4.48.
According to OA Biomarkers Network recommendation on 
osteoarthritis, study on biomarkers should be differentiated 
on its role in burden of disease, investigation, prognosis, 
efficacy and, diagnosis of OA.(20,21)
 Burden of disease markers assess the severity or 
extent of disease, typically at a single point of time, among 
individuals with OA. This can be thought of as severity 
within articular joint, and/or severity in terms of number of 
joints involved.(20) Several studies have shown that CTX-
II, HA, pyridinoline (PYD), cartilage oligomeric matrix 
protein (COMP), matrix metalloproteinase (MMP), tissue 
inhibitor of matrix metalloproteinase (TIMP), and YKL-D 
can be included in this category.(20,21)
 This study showed that CTX-II was signficantly 
correlated with knee OA severity. This result is in accordance 
to results of most studies (22,23,24,20,4). Conflicting 
results on CTX II was reported by Kalai who concluded that 
there was no significant correlation between CTX-II with 
a degree of joint gap narrowing.(16) Van Spil reported the 
lack of specificity of CTX-II  as a possible cause, finding 
that changes in CTX-II were not pararel with other cartilage 
specific biomarkers changes.(25) This could also be due to 
differences in subgroup populations between studies.
 The correlation of KL grade was significant with CTX-
II and HA. KL grades were not significantly associated with 
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Figure 1. Box Plot of CTX-II among the KL Groups.
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Figure 2. Box Plot of HA among the KL Group.
 The mean differences of CTX-I among KL II, III, 
and IV were not significant, p>0.05 (Table 2). The mean of 
CTX-II in KL IV was 1.004, which was significantly higher 
(mean=1004.9) than that in KL III (mean=731.14, p=0.021). 
The result also showed the mean differences of HA levels 
in KL IV were higher (mean=209.85) than those in KL III 
(mean=209.85) (p=0.151). No significant mean was found 
between CTX-I and OA severity. We found no correlation 
between inflammatory biomarkers (IL-1b, hs-CRP) and OA 
severity.
 The correlation of KL grade in Table 3 are shown 
significant with CTX-II (p=0.001, r=0.412) and HA 
(p=0.0411, r=0.269). Table 3 shows that KL grade was not 
significantly associated with CTX-I (p=0.8364, r=-0.0272); 
IL-1 β (p=0.5773, r=0.0853) and hs-CRP (p=0.2625, 
r=0.1470).
 Figure 1 and 2 show the mean difference of CTX-
II and HA among the KL grade II, grade III, and grade 
IV groups. The mean of CTX-II and HA are consistently 
increasing from KL grade II to grade III group, and from 
grade III group to grade IV group.
Discussion
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CTX-I, IL-1β and hs-CRP.
 In Mann-Whitney U test, no significant mean difference 
was found statistically between HA concentration and KL 
grade. These results are different compared to other studies.
(7-11,14) We exclude the possibility of HA fluctuation due 
to inflammatory condition because no significant difference 
of IL-1b and hs-CRP between groups was found in this 
study. In our opinion, this conflicting result might be due to 
small sample size because the trend showed higher HA in 
KL 3 and KL 4.
 The weakness of this study was that biomarkers 
fluctuation related to joint degradation process could not be 
adequately assessed by cross sectional method and small 
sample size might also affect result of the statistical analysis.
 Serum levels of CTX-I, CTX-II urine and serum HA 
might not represent the actual level inside the affected joint, 
since most of the patients had bilateral knees involvement. 
To minimize the bias, in this study we excluded subjects 
with multiple joints involvement and only included those 
with higher KL score in patients with bilateral knee OA. 
Thus with those study limitations, results of this study may 
not represent the general population, in particular due to the 
small sample size.
Conclusion
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